Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014


Drug Discovery & Development (DDD2014)

17 Jun 2014 - 18 Jun 2014 - Online Event



Bookmark and Share


SELECTBIO is pleased to invite you to attend the first of our innovative online conferences; Drug Discovery & Development (DDD 2014). Using a pioneering new platform especially developed for scientific events, this event will be broadcast to your PC or mobile device on 17th-18th June 2014.

During this event, the hottest topics in Drug Discovery will be addressed in a webinar-style auditorium with the opportunity for live Q&A at the end of each talk. Featuring an array of leading international speakers, this event aims to provide you with an insight into the latest developments in the design and development of drugs. Focus will be given to current developments in screening design, assay technology and compound management, as well as the emerging use of nanotechnology for drug delivery. Presentations will also highlight the increasing importance that academic centres play in drug discovery efforts, including drug repurposing and drug discovery for orphan diseases.
   
Benefits of attending this online event:

-    Opportunity to view posters, including an interactive session with the poster presenters.
-    Access to a virtual exhibit hall, enabling you to catch up with the latest technological developments in the industry via video, downloadable applications, brochures and interaction with booth staff.
-    View others in attendance and chat with them privately or in open forums.
-    No costs! No expensive flights, hotels or delegate fees.
-    Come & go as you please to fit around your busy life - you can attend at home or work using a PC or mobile device.

You can present your research on a poster while attending the meeting. Submit an abstract for consideration now!  Poster Submission Deadline: 06 June 2014





Further information
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Computerized Flexible Needles Prove Themselves in Biological Tissue
The advantage of the system is that you can avoid obstacles with the needles or critical tissues and that the system during the insertion of the needle in real time can adjust the path if, for example, the tissue deforms.
DARWIN 2 24-week Monotherapy Data in RA Confirm Previous Results
Safety profile in DARWIN 2 consistent with previous filgotinib RA studies.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Overdose of Vitamin D in Teenagers May Lead to Increased Cholesterol Levels
Dosing obese teens with vitamin D shows no benefits for their heart health or diabetes risk, and could have the unintended consequences of increasing cholesterol and fat-storing triglycerides. These are the latest findings in a series of Mayo Clinic studies in childhood obesity.
Phase 2 Trials Underway for New Single Dose Malaria Treatment
The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials in humans.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!